Combatting Bacterial Resistance in Europe

The Managing Entity Office at UMCU

As Managing Entity we work closely with the Coordinators and all Workpackage Leads of the three COMBACTE projects.  Good communication is key to making the projects successful! Read full article.


Currently twenty three sites have been initiated; in eight different countries. This month's top enrolling sites is Hospital Universitario Reina Sofia. Read full article

Country Visit Bulgaria

The aim of the country visit is to further consolidate the hospital and laboratory networks within COMBACTE, by meeting with the national coordinator(s) and visiting clinical and laboratory contacts Read full article


74 sites were selected, 51 are opened of which 29 locations have randomized subjects.  A total of 111 patients are randomized, 356 subjects screened to date, 3 of which are currently under screening . Read full article

First Ethical Approval for ASPIRE-SSI Study

COMBACTE-NET's ASPIRE-SSI study, received ethical approval on Tuesday October 11th from the Dutch Medical Ethics and Review Committee and will begin recruiting patients in the Netherlands. Read full article

REJUVENATE's Next Milestone in Sight

REJUVENATE is approaching the next big milestone: 9 of the 10 patients required for the early 10-patient-review have been recruited!. Read full article

ANTICIPATE First Patient In!

On Tuesday September 27th the University of Cologne (Uniklinik Köln, group of Maria Vehreschild & Oliver Cornely ) announced the enrollment of the first patient in the ANTICIPATE study. Read full article

Country visit  Italy

At the university hospital “IRCCS Fondazione Ca Granda Ospedale Maggiore Policlinico” COMBACTE met with the CLIN-Net national coordinator Prof. Francesco Blasi and his colleague Dr. Paolo Tarsia. Read full article
Got new ideas for the next newsletters?
Contact the PMO here!
Check out the newsroom for more news!
Upcoming Events

Federation of Infection Societies and Healthcare Infection Society Conference

Where Edinburgh, Scotland
When 6th of November
Duration Two Day Event

COMBACTE CLIN-Net and LAB-Net Country Visit

Where Bucharest, Romania
When 11th of January
Duration Two Day Event
This research project receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115523 | 115620 | 115737 resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution.